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Abstract
An obese patient with type 2 diabetes whose diet was changed from the recommended high-
carbohydrate, low-fat type to a low-carbohydrate diet showed a significant reduction in
bodyweight, improved glycemic control and a reversal of a six year long decline of renal function.
The reversal of the renal function was likely caused by both improved glycemic control and
elimination of the patient's obesity.
Insulin treatment in type 2 diabetes patients usually leads to weight increase which may cause
further injury to the kidney. Although other unknown metabolic mechanisms cannot be excluded,
it is likely that the obesity caused by the combination of high-carbohydrate diet and insulin in this
case contributed to the patient's deteriorating kidney function. In such patients, where control of
bodyweight and hyperglycemia is vital, a trial with a low-carbohydrate diet may be appropriate to
avoid the risk of adding obesity-associated renal failure to already failing kidneys.
Background
In Sweden the number of patients with type 2 diabetes
accompanied by end-stage renal failure has increased by
80 % since 1991 [1]. Control of blood glucose is crucial
because of the proven link between HbA1c and the rate of
decline of the kidney function in diabetic nephropathy
[2]. Metabolic control in such patients is, however, diffi-
cult because the recommended low-fat diet with its high
content of carbohydrates usually leads to a vicious cycle:
hyperglycemia caused by the high-carbohydrate diet
necessitates the use of insulin; efforts to normalise the
blood glucose with insulin leads to increase of appetite
and bodyweight [3]; the rise of bodyweight exposes the
patient to the risk of obesity-associated renal failure [4]. A
low-carbohydrate diet, however, is a potent antihypergly-
cemic remedy and may at the same time lead to weight
loss [5,6].
We report here a significant reduction in body weight,
improved glycemic control and reversal of a six year long
decline of renal function in a patient with type 2 diabetes,
whose diet we changed from the usually recommended
high-carbohydrate, low-fat type to the opposite.
Case report
The patient is a 60-year old man who was diagnosed with
type 2 diabetes in 1989 and had a family history of over-
weight and diabetes. Retinopathy was diagnosed in the
mid-90s. The patient had been treated several times with
focal laser photocoagulation. In 2003 he developed pro-
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liferative retinopathy and was treated with photocoagula-
tion. In addition to glimepiride and the ACE-inhibitor
quinapril, medication included metoprolol, furosemide,
simvastatin and aspirin. In 1995–1997, his blood pres-
sure (BP) was on average 125/90 mm Hg. Over the same
period, the patient's bodyweight varied between 89 kg
and 85 kg. Traditional dietary counselling for weight loss
usually resulted in a short-term loss of a few kg, but the
bodyweight soon increased again.
In July 1997 albuminuria was noted with a urine concen-
tration of 116 mg/l. That year the patient's average body
mass index (BMI) was 29.4 kg/m2 and the average body-
weight was 87.0 kg.
Insulin treatment was started four months later resulting
in a temporary improvement of HbA1c but an increase in
bodyweight. One year later, his BMI was 32.5 kg/m2 and
his weight was 94 kg. The insulin dose was lowered in
order to avoid further increase in bodyweight. In the years
1998–1999, following the weight increase and despite
improved glycemic control, his BP increased to an average
145/90 mm Hg. Likewise, urine albumin increased as
seen in the Figure. In 2000, despite a still reasonable glyc-
emic control but following further weight increase, the
albuminuria reached an average of more than 2000 mg/l
and the BP was 160/90 mm Hg. Both were controlled by
exchanging quinapril for the angiotensin II receptor
antagonist candesartan, and by adding amlopidine. The
BP has since been stable, averaging 130/76 (± 10/7) mm
Hg, but the decline of renal function continued. The Fig-
ure shows the albuminuria record and the increase in
HbA1c, serum creatinine and body weight with increasing
insulin dosage.
In January 2004 his diet was changed radically by reduc-
ing dietary carbohydrates to 80–90 g per day, consisting
only of vegetables and small amounts of hard bread (crisp
bread). Potatoes, bread, pasta, rice and cereals were
excluded, and the caloric requirements were covered by
protein and fat. To ease the transition the patient was sup-
plied with a number of meal recipes suggesting a caloric
restriction to about 1800 calories per day. The per cent
proportions of carbohydrates, fat and protein in the reci-
pes were 20 : 50: 30.
Less than two weeks later the patient discontinued his
insulin treatment and 6 months later his bodyweight had
decreased by 19 kg. HbA1c had dropped to 6.5 % after 3
months, and the steady rise of his serum creatinine
stopped. The creatinine has since – for two-and-a-half
years – been stable as seen in the figure. When insulin was
discontinued rosiglitazone was prescribed. In the Table
measured parameters are shown before the dietary
change, and now. As of late 2005 there was no sign of pro-
liferative disease in the patient's retinopathy.
Discussion
As early as two years after the appearance of albuminuria,
the patient had increased creatinine and urine albumin
and higher BP. This happened despite a significantly
improved glycemic control, although following an
increase of bodyweight. A change of medication did affect
BP and albuminuria but not the decline in kidney func-
tion. Only after a weight loss of 19 kg and an HbA1c
Creatinine, bodyweight, HbA1c, insulin doses and urine-albu- min Figure 1
Creatinine, bodyweight, HbA1c, insulin doses and 
urine-albumin. The figures shown are the average per year 
(including the first 5 months of 2006) before and after a 
change to a low-carbohydrate diet in an obese patient with 
type 2 diabetes and renal failure. Arrow: Start of low-carbo-
hydrate diet. Creatinine and urine albumin concentrations 
are given with ranges. Normal range: HbA1c <5.6 %. Creati-
nine 60–120 µmol/l. Urine albumin normal < 30 mg/l.
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reduction from a mean of about 8.5 % to 6.5 % was the
steady decline of the kidney function reversed.
Diabetic nephropathy normally progresses to end-stage
renal failure irrespective of the treatment. Only a com-
plete 24 hour normoglycemia, as seen after pancreas
transplants, can give the patient a chance to preserve the
remaining kidney function.
In the Diabetes Control and Complication Trial (DCCT) a
reduction of HbA1c from 9 % to 7 % (DCCT) led to a 40–
50 % reduction in the number of patients whose kidney
function deteriorated [2]. The reduction of HbA1c cannot
by itself explain the change of the rate of decline. Also the
HbA1c is far from normal. This level of hyperglycemia
would not be able to produce a reversal to a completely
preserved kidney function. Moreover, an almost normal-
ised HbA1c in the years following the commencement of
insulin treatment had no effect on the decline then.
Obesity and renal failure
Obesity is a strong risk factor for renal failure especially in
patients with diabetes and hypertension [4]. Even lean
persons with central body fat distribution are at risk of
having a lower rate of glomerular filtration [7]. An obes-
ity-related glomerulopathy has been described [8]. The
etiology may be ascribed to the fact that adipose tissue is
a source of hormones including angiotensinogen, renin
and leptin that may well influence renal function and BP
[9,10]. Numerous inflammatory mediators such as TNFα,
IL-6, resistin and others [11] are also secreted from fatty
tissue. These contribute to chronic inflammation, general
atherosclerosis and probably insulin resistance.
Beneficial effect of weight loss in proteinuric nephropathy
has been shown in a controlled study [12]. A weight
reduction of about 25 kg in an overweight diabetes patient
after gastric by-pass lowered the proteinuria by 84 % and
after further weight loss led to normalisation of a slightly
elevated creatinine [13]. Finally, two case reports have
described the partially resolving and stabilisation of dial-
ysis-requiring renal failure after weight loss following bar-
iatric surgery [14,15].
The common adverse effect of insulin treatment, the
increase in bodyweight, may have contributed to the dete-
rioration of the patient's kidney function in the years
before the dietary change. Some degree of insulin sensitiv-
ity in the adipocytes is necessary for weight increase. Dur-
ing the first couple of years, with relatively modest insulin
doses, the patient had a reasonable glycemic control while
he increased in weight, which points at some degree of
insulin sensitivity. By the year 2000, body weight may
have exceeded an individual threshold for the accumula-
tion of visceral fat after which insulin resistance increased
[16 ] necessitating more insulin.
It may be assumed that improved glycemic control as well
as weight loss contributed to stabilization of the patient's
kidney function. The actual mechanisms behind the
course of the patient's kidney disease are not known, how-
ever, and it cannot be excluded that other metabolic
changes have contributed to the improvement of the renal
function independently of weight loss. Even though other
unknown metabolic pathways and mechanisms may have
been involved, it is still unlikely that this patient would
have avoided dialysis if his diet had not been changed.
This is suggestive of a causal relationship between the diet
and the course of the patient's kidney disease.
Low-carbohydrate diet and weight loss
Low plasma insulin is a prerequisite for maximally stimu-
lating the hormone-sensitive lipase that is responsible for
lipolysis in fatty tissue. It therefore makes sense for an
obese diabetes patient to reduce the high intake of carbo-
hydrates. In this way the blood glucose is reduced and the
patient is able to diminish or discontinue insulin. In addi-
tion, a low-carbohydrate diet with ad libitum food intake
has been shown to be superior to the traditional calorie-
restricted, low-fat, high-carbohydrate diet for weight loss
in five randomised controlled studies [17-21]. The pri-
mary effect is caused by a lowering of appetite and a
caloric intake reduced to the appropriate level for the
patient's height [22].
The protein content of a diet may be a concern, but the
actual size of the effect of protein restriction is modest
[23,24]. It is also a misconception that a low-carbohydrate
diet automatically is high in protein. This misconception
Table 1: The measured parameters before the dietary change, 
and current.
January 2004 May 2006
Weight (kg) 102 81
BMI (kg/m 2 ) 34.5 27.4
Blood pressure (mm Hg) 135/75 130/75
§HbA1c (%) 9.4 6.5
§Creatinine (µmol/l) 269 215
§BUN (mmol/l) 15.3 14.4
§Urine-albumin (mg/l) 410 104
Cholesterol (mmol/l) 3.7 4.3
HDL (mmol/l) 0.8 1.3
Triglycerides (mmol/l) 1.8 2.1
Ratio Chol/HDL 4.6 3.3
Ratio TG/HDL 2.25 1.6
§ normal range: Creatinine = 60–120 µmmol/l; BUN = 3.2 – 8 mmol/l; 
urine-albumin <30 mg/l; HbA1c <5.6 %.Nutrition & Metabolism 2006, 3:23 http://www.nutritionandmetabolism.com/content/3/1/23
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may be a barrier for the use of a low-carbohydrate diet
which is a highly effective tool in the management of type
2 diabetes. Such a diet can be modified so it suits the
patient's needs i.e. the energy from carbohydrates can be
replaced by energy from dietary fat and not necessarily
from protein. The patient here was given a number of
meal recipes at start. The aim was to give him the means
to learn how to use this new dietary tool, which in essence
leads to a completely different mind-set regarding diet. He
was then recommended to consume about 70–90 g low-
starch carbohydrates per day and to eat more fat. The
patient is today still keeping the carbohydrates at the rec-
ommended level. He eats more fat and probably about
80–90 g of protein per day.
A motivating factor, in addition to being able to see that
the kidney function has stabilized, was probably the
increased feeling of well-being that followed very soon
after the dietary change. Within 1–2 weeks of the dietary
change – before any significant weight reduction had
occurred – poor sleep and chronic fatigue was exchanged
for a sound sleep pattern and increased vitality. This effect
soon allowed the patient to again involve himself wholly
in the running of his company. The reversal of the tired-
ness seen with chronic hyperglycemia may have been the
cause. It may be that reversal of carbohydrate-induced
memory impairment in type 2 diabetes played a role in
restoring the patient's alertness and self-confidence [25 ].
Conclusion
The present case report shows that a low-carbohydrate,
high-fat diet improves glycemic control, reduces body
weight and may prevent the development of end-stage
renal failure in an overweight patient with type-2 diabetes.
Furthermore, it raises the concern that the obesity caused
by the combination of a high-carbohydrate diet and insu-
lin may have contributed to the patient's failing kidney
function.
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